ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
peony-rose
|
52 |
9.2K |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
52
|
9.2K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
ASCO Presentations 2024
|
|
peony-rose
|
29 |
5.8K |
0 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
29
|
5.8K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
ASCO Presentations 2024
|
|
peony-rose
|
29 |
5.8K |
4 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
29
|
5.8K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
ASCO Presentations 2024
|
|
peony-rose
|
29 |
5.8K |
3 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
29
|
5.8K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Why no SPL announcement on TGA decison
|
|
peony-rose
|
13 |
2.2K |
2 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
13
|
2.2K
|
2
|
|
ASX - By Stock
|
HCW |
Re:
Ann: Trading Update
|
|
peony-rose
|
4 |
2.0K |
0 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
4
|
2.0K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
peony-rose
|
148 |
28K |
4 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
148
|
28K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Investor Webinar Notification SPL Medicxi Partnership
|
|
peony-rose
|
32 |
6.3K |
1 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
32
|
6.3K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
peony-rose
|
148 |
28K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
148
|
28K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
peony-rose
|
148 |
28K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
148
|
28K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
peony-rose
|
148 |
28K |
9 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
148
|
28K
|
9
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
peony-rose
|
148 |
28K |
7 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
148
|
28K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
peony-rose
|
148 |
28K |
8 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
148
|
28K
|
8
|
|
ASX - By Stock
|
SPL |
Re:
Interim decision to amend the Poison Standard for astodrimer sodium
|
|
peony-rose
|
32 |
7.6K |
7 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
32
|
7.6K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma's new website
|
|
peony-rose
|
5 |
1.0K |
0 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
5
|
1.0K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma's website has been updated
|
|
peony-rose
|
23 |
5.3K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
23
|
5.3K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma's website has been updated
|
|
peony-rose
|
23 |
5.3K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
23
|
5.3K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
History
|
|
peony-rose
|
83 |
15K |
4 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
83
|
15K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Another day, another record low.
|
|
peony-rose
|
11 |
2.5K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
11
|
2.5K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Letter from Cheryl..
|
|
peony-rose
|
72 |
16K |
6 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
72
|
16K
|
6
|
|
ASX - By Stock
|
FMG |
Re:
FMG Technical Analysis
|
|
peony-rose
|
11K |
10M |
0 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
11K
|
10M
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Covid-19 is not over by a long shot ladies and gentlemen
|
|
peony-rose
|
102 |
21K |
2 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
102
|
21K
|
2
|
|
ASX - By Stock
|
SVW |
Re:
Ann: Interim Results Announcement
|
|
peony-rose
|
4 |
925 |
1 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
4
|
925
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Viraleze shows antiviral efficacy in COVID-19 patients
|
|
peony-rose
|
74 |
14K |
1 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
74
|
14K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VivaGel BV sales and distribution agreement MENA region
|
|
peony-rose
|
37 |
8.3K |
1 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
37
|
8.3K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VivaGel BV sales and distribution agreement MENA region
|
|
peony-rose
|
37 |
8.3K |
0 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
37
|
8.3K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VivaGel BV sales and distribution agreement MENA region
|
|
peony-rose
|
37 |
8.3K |
2 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
37
|
8.3K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Dawn of a new era come Monday 8th of January
|
|
peony-rose
|
38 |
7.0K |
2 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
38
|
7.0K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma to rebrand Vivagel
|
|
peony-rose
|
9 |
2.4K |
5 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
9
|
2.4K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Shareholders Meeting
|
|
peony-rose
|
9 |
1.4K |
2 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
9
|
1.4K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Keeping shareholders in the loop
|
|
peony-rose
|
46 |
9.6K |
1 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
46
|
9.6K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
New CEO’s focus
|
|
peony-rose
|
85 |
19K |
6 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
85
|
19K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
May New Year bring good Viraleze news and SPL
|
|
peony-rose
|
11 |
2.7K |
1 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
11
|
2.7K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Keeping shareholders in the loop
|
|
peony-rose
|
46 |
9.6K |
2 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
46
|
9.6K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze clinical trial results
|
|
peony-rose
|
4 |
1.3K |
7 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
4
|
1.3K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
The Armageddon scenario
|
|
peony-rose
|
46 |
10K |
2 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
46
|
10K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
The window is now open - D day is here
|
|
peony-rose
|
43 |
11K |
3 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
43
|
11K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma announces new CEO, Ms Cheryl Maley
|
|
peony-rose
|
91 |
24K |
2 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
91
|
24K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Is this finally the start of run
|
|
peony-rose
|
30 |
7.4K |
0 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
30
|
7.4K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Is this finally the start of run
|
|
peony-rose
|
30 |
7.4K |
0 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
30
|
7.4K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Is this finally the start of run
|
|
peony-rose
|
30 |
7.4K |
1 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
30
|
7.4K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma announces new CEO, Ms Cheryl Maley
|
|
peony-rose
|
91 |
24K |
1 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
91
|
24K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Sale of DEP platform?
|
|
peony-rose
|
25 |
5.1K |
2 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
25
|
5.1K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Somebody’s heard something???
|
|
peony-rose
|
4 |
1.0K |
0 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
4
|
1.0K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive DEP Cabazitaxel Phase 2 Results in Multiple Cancer
|
|
peony-rose
|
73 |
18K |
2 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
73
|
18K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Ceasing to be a substantial holder
|
|
peony-rose
|
9 |
2.0K |
0 |
16/10/23 |
16/10/23 |
ASX - By Stock
|
9
|
2.0K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Sanofi Annual Report 2022
|
|
peony-rose
|
17 |
4.1K |
5 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
17
|
4.1K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Here we Go!
|
|
peony-rose
|
20 |
4.5K |
3 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
20
|
4.5K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Optimism
|
|
peony-rose
|
94 |
21K |
4 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
94
|
21K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive DEP irinotecan clinical results presentation
|
|
peony-rose
|
56 |
14K |
1 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
56
|
14K
|
1
|
|